These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 21725256)
21. Durability of Hearing Preservation Following Microsurgical Resection of Vestibular Schwannoma. Dowling EM; Patel NS; Lohse CM; Driscoll CLW; Neff BA; Van Gompel JJ; Link MJ; Carlson ML Otol Neurotol; 2019 Dec; 40(10):1363-1372. PubMed ID: 31725593 [TBL] [Abstract][Full Text] [Related]
22. Analysis of hearing preservation and facial nerve function for patients undergoing vestibular schwannoma surgery: the middle cranial fossa approach versus the retrosigmoid approach--personal experience and literature review. Rabelo de Freitas M; Russo A; Sequino G; Piccirillo E; Sanna M Audiol Neurootol; 2012; 17(2):71-81. PubMed ID: 21829012 [TBL] [Abstract][Full Text] [Related]
23. Lesions of the internal auditory canal and cerebellopontine angle in an only hearing ear: is surgery ever advisable? Driscoll CL; Jackler RK; Pitts LH; Brackmann DE Am J Otol; 2000 Jul; 21(4):573-81. PubMed ID: 10912705 [TBL] [Abstract][Full Text] [Related]
24. Acoustic neuromas presenting with normal or symmetrical hearing: factors associated with diagnosis and outcome. Lustig LR; Rifkin S; Jackler RK; Pitts LH Am J Otol; 1998 Mar; 19(2):212-8. PubMed ID: 9520059 [TBL] [Abstract][Full Text] [Related]
25. Hearing preservation rates after microsurgical resection of vestibular schwannoma. Sughrue ME; Yang I; Aranda D; Kane AJ; Parsa AT J Clin Neurosci; 2010 Sep; 17(9):1126-9. PubMed ID: 20627586 [TBL] [Abstract][Full Text] [Related]
26. Late failure rate of hearing preservation after middle fossa approach for resection of vestibular schwannoma. Hilton CW; Haines SJ; Agrawal A; Levine SC Otol Neurotol; 2011 Jan; 32(1):132-5. PubMed ID: 21099729 [TBL] [Abstract][Full Text] [Related]
27. Intraoperative cochlear nerve monitoring in vestibular schwannoma surgery--does it really affect hearing outcome? Piccirillo E; Hiraumi H; Hamada M; Russo A; De Stefano A; Sanna M Audiol Neurootol; 2008; 13(1):58-64. PubMed ID: 17890858 [TBL] [Abstract][Full Text] [Related]
28. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104 [TBL] [Abstract][Full Text] [Related]
29. Factors associated with hearing outcomes after a middle fossa approach in 131 consecutive patients with vestibular schwannomas. Budohoski KP; Rennert RC; Gordon SA; Raheja A; Brandon C; Henson JC; Azab MA; Patel NS; Karsy M; Gurgel RK; Shelton C; Couldwell WT J Neurosurg; 2023 Aug; 139(2):432-441. PubMed ID: 36461828 [TBL] [Abstract][Full Text] [Related]
30. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900 [TBL] [Abstract][Full Text] [Related]
31. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium. Fisher LM; Doherty JK; Lev MH; Slattery WH Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365 [TBL] [Abstract][Full Text] [Related]
32. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2. Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779 [TBL] [Abstract][Full Text] [Related]
33. Functional outcome of retrosigmoid approach in vestibular schwannoma surgery. Yang J; Grayeli AB; Barylyak R; Elgarem H Acta Otolaryngol; 2008 Aug; 128(8):881-6. PubMed ID: 18607969 [TBL] [Abstract][Full Text] [Related]
34. Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach. Ginzkey C; Scheich M; Harnisch W; Bonn V; Ehrmann-Müller D; Shehata-Dieler W; Mlynski R; Hagen R Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1209-16. PubMed ID: 22722943 [TBL] [Abstract][Full Text] [Related]
35. Surgical management of jugular foramen schwannomas with hearing and facial nerve function preservation: a series of 23 cases and review of the literature. Sanna M; Bacciu A; Falcioni M; Taibah A Laryngoscope; 2006 Dec; 116(12):2191-204. PubMed ID: 17146395 [TBL] [Abstract][Full Text] [Related]
36. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients. Convert C; Franco-Vidal V; Bebear JP; Darrouzet V Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517 [TBL] [Abstract][Full Text] [Related]
37. Immediate and Long-term Hearing Outcomes With the Middle Cranial Fossa Approach for Vestibular Schwannoma Resection. Ahmed S; Arts HA; El-Kashlan H; Basura GJ; Thompson BG; Telian SA Otol Neurotol; 2018 Jan; 39(1):92-98. PubMed ID: 29227454 [TBL] [Abstract][Full Text] [Related]
38. Hearing preservation surgery in vestibular schwannoma: the hidden truth. Sanna M; Khrais T; Russo A; Piccirillo E; Augurio A Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):156-63. PubMed ID: 14994774 [TBL] [Abstract][Full Text] [Related]
40. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation. Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]